Quick Answer
Passage BIO, Inc. reported Net Income of -$45.52 million for fiscal year 2025.
Passage BIO, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$45.52M | +29.7% |
| 2024 | -$64.77M | +36.5% |
| 2023 | -$102.06M | +25.0% |
| 2022 | -$136.12M | +26.6% |
| 2021 | -$185.39M | -65.2% |
| 2020 | -$112.23M | -145.9% |
| 2019 | -$45.63M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.75M | +59.9% | +17.4% |
| June 30, 2025 | -$9.38M | +41.3% | +39.1% |
| March 31, 2025 | -$15.40M | +7.8% | +20.3% |
| September 30, 2024 | -$19.34M | +28.7% | -20.9% |
| June 30, 2024 | -$15.99M | +33.0% | +4.3% |
| March 31, 2024 | -$16.71M | +51.3% | +38.4% |
| September 30, 2023 | -$27.11M | -1.5% | -13.6% |
| June 30, 2023 | -$23.86M | +39.7% | +30.5% |
- Passage BIO, Inc. showed an increase of +29.7% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Passage BIO, Inc.’s net income has grown by 0.2% (from -$45.63 million to -$45.52 million).
- The most recent figure is from Passage BIO, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: